Trademarkia Logo

Canada

C$
CELLUSION
APPROVED

on 26 Mar 2025

Last Applicant/ Owned by

Cellusion Inc.

2-5-24, Harumi,Chuo-kuTokyo 104-0053

JP

Serial Number

2230633 filed on 3rd Aug 2022

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

CELLUSION

Trademark usage description

oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmac Read More

Classification Information


Class [005]
Oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for veterinary purposes; eyepatches for medical purposes; dental materials, namely dental materials for stopping the teeth, abrasive fluids for dental purposes, adhesives for dental purposes, amalgam for dental purposes, cements for dental prostheses, composite materials for dental purposes, dental blanks, dental implant materials, dental wax, embedding material for dental purposes, material for dental prostheses, materials for dental fillings.


Classification kind code

11

Class [042]
Testing, inspection and research of pharmaceuticals; consulting services in the field of pharmaceutical testing, inspection and research; pharmaceutical research and development; clinical trials; medical research; biological research in the field of regenerative medicine, cell therapy and gene therapy; providing information about medical research in the field of medicine; providing information in the field of testing, inspection and research of using stem cells in the field of regenerative medicine, cell medicine, and gene therapy; providing information in the field of research and development of pharmaceutical preparations; pharmaceutical drug development services; culturing of cells for scientific research purposes in the field of regenerative medicine, cell medicine, and gene therapy; testing, inspection and research of medical treatment methods and techniques in the field of regenerative medicine, cell therapy and gene therapy; testing, inspection and research of cosmetics and foodstuffs; scientific research in the field of genetic engineering; scientific services namely the isolation and cultivation of human tissues and cells in the field of regenerative medicine, cell medicine and gene therapy; analysis of stem cells for scientific research purposes; research and development services in the field of gene expression systems; testing, inspection or research of regenerative medicine services; testing, inspection and scientific research and medical research in the field of regenerative medicine, cell medicine and gene therapy; testing and research services relating to medical apparatus and medical instruments in the field of regenerative medicine, cell therapy and gene therapy; design and development of computer hardware and software for use in the field of medicine; designing of medical apparatus and instruments; computer software design, computer programming, or maintenance of computer software; providing computer programs for data processing in the field of regenerative medicine, cell therapy and gene therapy on data networks; rental of laboratory equipment and instruments; culturing of cells for others for scientific research purposes in the field of regenerative medicine, cell medicine and gene therapy; genetic testing of cells for scientific research purposes in the field of regenerative medicine, cell medicine and gene therapy; culturing of cells collected from patients for scientific research purposes, namely, for transplantation in the field of regenerative medicine, cell medicine, and gene therapy; providing quality assurance services in the field of therapeutic compositions, namely, compositions containing cells for regenerative medicine services, gene therapy, and viruses; quality assurance consultancy services in the field of therapeutic compositions, namely, compositions containing cells for regenerative medicine services, gene therapy, and viruses; providing quality control for the pharmaceutical industry, providing quality control in the field of therapeutic compositions, namely, compositions containing cells for regenerative medicine services, gene therapy, and viruses; consultancy services in the field of quality control for the pharmaceutical industry, consultancy services in the field of quality control in the field of therapeutic compositions, namely, compositions containing cells for regenerative medicine services, gene therapy, and viruses.


Classification kind code

11

Class [044]
Providing medical information in the field of regenerative medicine, cell therapy, and gene therapy; medical and veterinary information services provided via the Internet; providing information to patients in the field of administering medication; medical care and analysis services relating to patient treatment; health clinic services namely dental clinics, emergency medicine clinics, medical clinic services, medical clinics, medical treatment services provided by clinics and hospitals, mobile medical clinic services, operation and management of medical clinics, veterinary clinics, health clinic services in the field of regenerative medicine services; collection, analysis, and provision of information in the field of medical care; treatment or diagnosis using regenerative medicine services; treatment or diagnosis in the field of stem cell medicine; dietary and nutritional guidance; animal husbandry; veterinary services; medical equipment rental; providing medical and pharmaceutical consultancy and information services relating to biopharmaceutical products; cultured cell bank services for medical transplantation in the field of regenerative medicine, cell medicine, and gene therapy; medical treatment using cultured cells in the field of regenerative medicine, cell medicine, and gene therapy; stem cell bank services in the field of regenerative medicine, cell medicine, and gene therapy; stem cell therapy services in the field of regenerative medicine, cell medicine, and gene therapy; providing medical information in the field of collection and preservation of cells in the field of regenerative medicine, cell medicine, and gene therapy; providing medical information in the field of analysis and processing cells in the field of regenerative medicine, cell medicine, and gene therapy; providing medical information in the field of regenerative medicine services; collection and preservation of biological tissues, blood and cells in the field of regenerative medicine, cell medicine, and gene therapy; medical testing services relating to the diagnosis and treatment of disease performed by culturing medical and clinical cells in the field of regenerative medicine, cell medicine, and gene therapy; medical services namely analysis and processing of blood plasma and stem cells being medical services, medical services relating to the removal, treatment and processing of stem cells, conducting of medical examinations, cultured cell bank services for medical transplantation, genetic testing for medical purposes, information, advisory and consultancy services in the field of medical care and analysis services, information, advisory and consultancy services in the field of medical testing services; providing information and medical data for diagnosis and medical treatment in the field of regenerative medicine, cell therapy, and gene therapy; medical treatment services with cell preparations in the field of regenerative medicine, cell medicine, and gene therapy; medical professional consulting services in the field of regenerative medicine, cell medicine, and gene therapy; preservation of human blood for use as a source of stem cells in the field of regenerative medicine, cell medicine, and gene therapy; genetic testing for medical purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories.


Classification kind code

11

Mark Details


Serial Number

2230633

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 2th Apr 2024
Search Recorded
Submitted for opposition 20
on 2th Apr 2024
Examiner's First Report
Submitted for opposition 135
on 7th Mar 2024
Amendment to Application
Submitted for opposition 256
on 30th Oct 2023
Notification of Possible Opposition Sent
Submitted for opposition 135
on 9th Mar 2023
Amendment to Application
Submitted for opposition 257
on 29th Dec 2022
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 28th Dec 2022
Formalized
Submitted for opposition 1
on 28th Dec 2022
Created
Submitted for opposition 228
on 3rd Aug 2022
International Registration
Submitted for opposition 30
on 3rd Aug 2022
Filed